6505--Intent to sole source Pylarify PSMA PET prostate cancer imaging agent- VISN 2 Down State
Closed Special Notice Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- 36C24222Q0053
- Agency
-
Veterans Integrated Service Network 2
Veterans Health Administration, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
Notice details come from SAM.gov. Updated .
About this opportunity
This Special Notice was published by the Department of Veterans Affairs Network Contracting Office 2. The Notice communicates the agency's intent to award a sole source contract to Progenics Pharmaceuticals, Inc. through their distributor Sofie for deliveries of the Pylarify prostate cancer imaging agent.
The Notice aims to provide Pylarify to VA medical facilities in New York Harbor, New Jersey, Northport and the Bronx for detecting prostate cancer metastasis or recurrence. Interested parties have until October 28, 2021 to respond to the Notice to be considered for future procurements. The contract would be for one year under NAICS code 325412 for pharmaceutical preparation manufacturing and FSC 6505 for drugs and biologicals. Pylarify is the only prostate cancer imaging agent that meets the needs of the agency according to the Notice.
Notice text
2 versions
Update #2 · Latest ·
NOTICE OF INTENT TO SOLE SOURCE Department of Veterans Affairs (VA) Network Contracting Office 2 (NCO 2) hereby gives notice of the Government s intent to sole source a purchase order for a period of performance of 1 year with Progenics Pharmaceuticals, Inc. through their sole Northeast Distributor Sofie, for Pylarify prostate-specific membrane antigen (PSMA) positive emission tomography (PET) prostate cancer imaging agent deliveries at the VISN 2 Down State Facilities, New York Harbor, New Jersey, Northport and Bronx VAMC s. Pylarify, (Piflufolastat F-18), is a radioactive diagnostic agent indicated for positive emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer. It can be used for men with suspected metastasis who are candidates for initial definitive therapy or those with suspected recurrence based on elevated serum prostate-specific antigen (PSA) level. It is the Government s belief that the proposed candidate is the only provider of PSMA PET prostate cancer imaging agent that can meet the agency s needs. The applicable North American Industry Classification System (NAICS) code is 325412 (Pharmaceutical Preparation Manufacturing) with a small business size standard of 1,250 employees and the Federal Supply Code (FSC) is 6505(Drugs and Biologicals). This notice of intent is not a request for competitive quotes and no solicitation will be made available. Any response received NLT October 28, 2021 at 3PM will be considered for the purposed of determining sources for future procurements Tina.Cavalieri@va.gov. Supporting evidence must be furnished in sufficient detail to demonstrate the ability to comply with the above requirement. A determination by the Government not to compete the proposed acquisition based upon responses of this notice is solely within the discretion of the Government. No telephone inquiries will be accepted. THIS SYNOPSIS DOES NOT COMMIT THE GOVERNMENT TO CONTRACT FOR ANY SUPPLY OR SERVICE. THE GOVERNMENT WILL NOT PAY FOR ANY INFORMATION OR ADMINISTRATIVE COSTS INCURRED IN RESPONSE TO THIS SYNOPSIS. This will be the only notice of the Government s intent to solicit, negotiate, and award to one source to satisfy this requirement.
Update #1 ·
NOTICE OF INTENT TO SOLE SOURCE
Department of Veterans Affairs (VA) Network Contracting Office 2 (NCO 2) hereby gives notice of the Government s intent to sole source a purchase order for a period of performance of 1 year with Progenics Pharmaceuticals, Inc. through their sole Northeast Distributor Sofie, for Pylarify prostate-specific membrane antigen (PSMA) positive emission tomography (PET) prostate cancer imaging agent deliveries at the VISN 2 Down State Facilities, New York Harbor, New Jersey, Northport and Bronx VAMC s.
Pylarify, (Piflufolastat F-18), is a radioactive diagnostic agent indicated for positive emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer. It can be used for men with suspected metastasis who are candidates for initial definitive therapy or those with suspected recurrence based on elevated serum prostate-specific antigen (PSA) level.
It is the Government s belief that the proposed candidate is the only provider of PSMA PET prostate cancer imaging agent that can meet the agency s needs. The applicable North American Industry Classification System (NAICS) code is 325412 (Pharmaceutical Preparation Manufacturing) with a small business size standard of 1,250 employees and the Federal Supply Code (FSC) is 6505(Drugs and Biologicals).
This notice of intent is not a request for competitive quotes and no solicitation will be made available. Any response received NLT October 28, 2021 at 3PM will be considered for the purposed of determining sources for future procurements Tina.Cavalieri@va.gov. Supporting evidence must be furnished in sufficient detail to demonstrate the ability to comply with the above requirement. A determination by the Government not to compete the proposed acquisition based upon responses of this notice is solely within the discretion of the Government. No telephone inquiries will be accepted.
THIS SYNOPSIS DOES NOT COMMIT THE GOVERNMENT TO CONTRACT FOR ANY SUPPLY OR SERVICE. THE GOVERNMENT WILL NOT PAY FOR ANY INFORMATION OR ADMINISTRATIVE COSTS INCURRED IN RESPONSE TO THIS SYNOPSIS.
This will be the only notice of the Government s intent to solicit, negotiate, and award to one source to satisfy this requirement.
Files
| File | Type | Posted |
|---|---|---|
| 36C24222Q0053.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6505--Intent to sole source Pylarify PSMA PET prostate cancer imaging agent- VISN 2 Down State | Award Notice | |
| This notice | Special Notice |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--VA Long Beach Pylarify | Veterans Integrated Service Network 22 | No set-aside | |
| 6505--INTENT TO SOLE SOURCE Radiopharm - Lutathera & Pluvicto - Lebanon VAMC | Veterans Integrated Service Network 4 | No set-aside | |
| 6515--Notice of Intent to Award Sole Source - TEE PROBE TRANSDUCER | Veterans Integrated Service Network 2 | No set-aside | |
| J065--Philips Imaging Equipment Full-services for Bronx | Veterans Integrated Service Network 2 | No set-aside | |
| J065--Philips Imaging Equipment Service Maintenance NYH | Veterans Integrated Service Network 2 | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity